Welcome to NRG Oncology!

Welcome to the NRG Oncology Web site! This resource serves to provide current information about NRG Oncology’s exciting research future and the latest updates about plans to support our clinical trial endeavors. We invite you to check back often to learn “what’s new.”

About NRG Oncology

NRG Oncology brings together the unique and complementary research areas of the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG). NRG Oncology builds upon our more than 150 years of cumulative research experience to conduct practice defining, multi-institutional clinical trials resulting in the improved survival and quality of life of patients with cancer. NRG Oncology has been awarded a grant by the National Cancer Institute (NCI) as a member of the NCI National Clinical Trials Network (NCTN).


Click here to access all weekly broadcasts


NCORP Badge English636404806468909532

NRG Oncology is proud to be an 
active participant of Cancer Moonshot.




Learn about the leaders and plans for NRG Oncology's NCORP Research Base.


NRG Oncology
Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103
Contact Us

To receive the NRG Oncology Newsletter and occasional eNews announcements and press releases, please email

What’s New

Call for research proposals: seeking a ctDNA assay partner as an integral biomarker in an upcoming colorectal cancer study. Please see RFA. Read more

The NRG Oncology Protocol Support Committee will be accepting applications until October 21, 2019. Read more

A Letter from the NRG Oncology Group Chairs on Rare Tumor Trials Read more

Oncology Substudy Show Cosmetic Changes are Equivalent after Whole Breast Irradiation versus Partial Breast Irradiation for Women with Early Stage Breast Cancer Read more

Reduced-Dose Intensity-Modulated Radiotherapy with Cisplatin Meets Predetermined Benchmarks for Progression-Free Survival and Swallowing-Related Quality of Life for Oropharyngeal Cancer Read more

NRG Oncology Trial Shows no Difference in Pain Response between Stereotactic Body Radiotherapy and Conventional Radiotherapy for Patients with Spinal Metastases Read more

Pre-Salvage RT PSA is Predictive of Hormone Therapy Benefit with Salvage RT for Men with Recurrent Prostate Cancer on NRG Oncology Trial Read more

NRG Oncology has 4 plenary session talks at ASTRO 2019 Read more

NRG Oncology research at ASTRO 2019 Read more

The NRG post-meeting eNewsletter for July 2019 is now available Read more

NRG Oncology is seeking an experienced Patient Advocate to serve as Chair for its Patient Advocate Committee Read more

Don't miss these sessions at #NRG19 Read more

NRG Oncology Trial Reaffirms Carboplatin and Paclitaxel Chemotherapy Alone Should Remain Standard Treatment for Endometrial Cancer Read more

Patients who Received Partial Breast Irradiation without Chemotherapy Experienced Less Fatigue, Slightly Poorer Cosmesis on NRG Oncology Trial Read more 

NRG Oncology Trial Sets New Standard Regimen for Women with Uterine Carcinosarcomas Read more

Analyses of NRG Oncology/RTOG 9802 Suggests Both IDH-mutant WHO-defined Molecular Subgroups of High-risk Low-Grade Gliomas May Benefit from the Addition of PCV Chemotherapy to Radiotherapy Read more

Initial Experimental Treatment Arm Results from NRG Oncology Trial Suggests Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer is Safe Read more

NRG Oncology Trial Shows Tolerability of Metformin for Non-Small Cell Lung Cancer, No Improvement in Survival Outcomes between Treatments  Read more

The NRG Oncology Newsletter for May 2019 is now available Read more

Do not miss these NRG Oncology presentations at the ASCO Meeting Read more

NEW! NRG Oncology is issuing the ASCO 2019 schedule so that meeting attendees are able to plan on seeing the posters and presentations on NRG Oncology research. Read more

Patient Reported Outcomes: Upping the game for PRO methods and design in clinical trials
NRG Oncology will be holding a workshop at the NRG Semiannual Meeting related to improving statistical methods to meet study goals, analyzing longitudinal PRO data as well as a panel discussion with NCORP PIs. This session will be held on Thursday, July 18, 2019 from 1-5 pm ET and will be open to all attendees. More information on the session and agenda will be released soon.


Project Team Member Application – Abemaciclib Read more

NRG Oncology SDMC Awarded NCI Funding for Next 6 Years with ‘Outstanding’ Score Read more

NRG Oncology Awarded NCI Funding for Next 6 Years, Receives “Exceptional” Score Read more

Program Announcement: Cancer Moonshot Initiative on Retrospective Characterization of Biospecimens from NCI-sponsored NCTN and NCORP Trials Read more


Hurricane Florence Notice: Potential Impact on NRG Oncology Research
Hurricane Florence Notice: Potential Impact on NRG Oncology Research

Copyright 2019 by NRG Oncology